The cost-effectiveness of placing urinary tract infection treatment over the counter

Journal of Clinical Epidemiology

Volumn 49, Issue 11, 1996, Pages 1315-1321

  Rubin, Nicole ^a   Foxman, Betsy ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antibiotics; Cost effectiveness analysis; Over the counter; Resistance; Treatment; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT; NON PRESCRIPTION DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CONSULTATION; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE ACCESS; HEALTH ECONOMICS; HUMAN; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION; PRIORITY JOURNAL; SYMPTOM; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DIAGNOSTIC ERRORS; DRUG RESISTANCE, MICROBIAL; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; SENSITIVITY AND SPECIFICITY; URINARY TRACT INFECTIONS;

EID: 0030297562     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(96)00218-1     Document Type: Article

References (43)

1. 1. Segal M. Rx to OTC: The switch is on. FDA Consumer Magazine DHHS Publication No. (FDA) 92-3195.
2. 2. Gossel TA. Implications of the reclassification of drugs from prescription-only to over-the-counter status. Clin Therapeut 1991; 13(2): 201-215.
3. 3. Rosenau PV. Rx-to-OTC movement. Med Care Rev 1994; 51 (4): 429-466.
4. 4. Tanouye E, Burton TM. Medicine: More firms "switch" prescription drugs to give them over-the-counter status. Wall Street Journal 1993; Thursday July 29: B1.
5. 5. Stamm WE, Hooton TM, Johnson JR, Stapleton A, Roberts PL, Moseley SL, Fihn SD. Urinary tract infections: From pathogenesis to treatment. J Infect Dis 1989; 159(3): 400-406.
6. 6. Elder NC. Acute urinary tract infection in women: What kind of antibiotic therapy is optimal? Postgrad Med 1992; 92(6): 159-162.
7. 7. Kunin CM. Urinary tract infections in females. Clin Infect Dis 1994; 18: 1-12.
8. 8. Johnson JR, Stamm WE. Urinary tract infections in women: Diagnosis and treatment. Ann Intern Med 1989; 111: 906-917.
9. 9. Mabeck CE. Treatment of uncomplicated urinary tract infection in non-pregnant women. Postgrad Med 1972; 48: 69-75.
10. 10. Nicolle LE. The optimal management of lower urinary tract infections. Infection 1990; 18(2): 50-52.
11. 11. Stamm WE, Hooten TM. Management of urinary tract infections in adults. New Engl J Med 1993; 329: 1328-1334.
12. 12. Kunin CM. Detection, Prevention and Management of Urinary Tract Infections, 4th ed. Philadelphia: Lea & Febiger, 1987.
13. 13. Doyle C. Milestone Status of OTC Drug Review Documents. June 22, 1993. HFD-820.
14. 14. Center for Drug Evaluation and Research. The OTC Drug Review Fact Sheet. Rockville, MD, US Food and Drug Administration, 1990.
15. 15. Sherif K. Antifungal medications for vaginal yeast infections. Network News 1993; 18(2): 2.
16. 16. Taylor Calipsky MS. Physicians' perceptions of the impact of the reclassification of vaginal antifungal agents. J Fam Prac 1994; 38(2): 157-160.
17. 17. Spinillo A, Nicola S, Colonna L, Marangoni E, Cavanna C, Michelone G. Frequency and significance of drug resistance in vulvovaginal candidiasis. Gynecol Obstet Invest 1994; 38(2): 130-133.
18. 18. Sohel JD. Controversial aspects in the management of vulvovaginal candidiasis. J Am Acad Dermatol 1994; 31(3 Pt. 2): S10-S13.
19. 19. Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982; 307: 463-468.
20. 20. Denman SJ and William BG III. Genitourinary infections. In: Barker LR, Burton JR, and Zieve PD, Eds. Principles of Ambulatory Medicine. Baltimore: Williams & Wilkins; 1993.
21. 21. Stamm WE, McKevitt M, Roberts PL, White NJ. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991; 13: 77-84.
22. 22. McGinley L. FDA urged to bar nonprescription sales of acyclovir. Wall Street Journal 1995; January 13: B4.
23. 23. Hatziandreu EI, Koplan JP, Weinstein MC, Caspersen CJ, Warner KE. A cost-effectiveness analysis of exercise as a health promotion activity. Am J Public Health 1988; 78(11): 1417-1421.
24. 24. Udvarhelyi IS, Graham AC, Rai A, Epstein AM. Cost-effectiveness and cost-benefit: analyses in the medical literature: Are the methods being used correctly? Ann Intern Med 1992; 116: 238-244.
25. 25. Baumol WJ. On the social discount rate. Am Econ Rev 1968; 58(4): 788-802.
26. 26. Marglin SA. The social rate of discount and the optimal rate of investment. Q J Econ 1963; 77(1): 95-112.
27. 27. Evans DA, Williams DN, Laughlin LW, Miao L, Warren JW, Hennekens CH, Chimada J, Chapman WG, Rosner B, Taylor JO. Bacteriuria in a population-based cohort of women. J Infect Dis 1978; 138(6): 768-773.
28. 28. Grob PR. Urinary tract infection in general practice: Practical problems. Practitioner 1978; 221: 237-241.
29. 29. Foxman B. Recurring urinary tract infection: Incidence and risk factors. Am J Public Health 1990; 80(3): 331-333.
30. 30. Hooton TM, Roberts RL, Stamm WE. Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis 1994; 19: 274-278.
31. 31. Zielske JV, Lohr KN, Brook H, Goldberg GA. Conceptualization and Measurement of Physiologic Health for Adults, Vol. 16: Urinary Tract Infection. R-2262/16-HHS, Rand Corporation, Santa Monica; 1981.
32. 32. 1995 Red Book. Montvale, New Jersey: Medical Economics Data, Inc.; 1995.
33. 33. Lakoski G. Rx to OTC. Am Druggist 1992; December: 47-48.
34. 34. Hooton TM, Winter C, Tiu F, Stamm WE. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA 1995; 273: 41-45.
35. 35. Foxman B, Frerichs RR. Epidemiology of urinary tract infection. II. Diet, clothing, and urination habits. Am J Public Health 1985; 75: 1314-1317.
36. 36. Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women: Diagnosis and treatment. Infect Dis Clin North Am 1987; 1(4): 793-806.
37. 37. Casner PR. Antibiotics over the counter and across the border. (Letter.) Ann Intern Med 1984; 100(3): 462-463.
38. 38. Kunin CM. Antibiotic resistance - A world health problem we cannot ignore. (Editorial.) Ann Intern Med 1983; 99: 859-860.
39. 39. Sepkowitz KA, Telzak EE, Recalde S, Armstrong D. Trends in the susceptibility ot tuberculosis in New York City, 1987-1991. New York City Area Tuberculosis Working Group. Clin Infect Dis 1994; 18(5): 755-759.
40. 40. Wenzel RP, Kunin CM. Should oral antimicrobial drugs be available over the counter? J Infect Dis 1994; 170: 1256-1259.
41. 41. Kunin CM, White LV, Hua TH. A reassessment of the importance of "low-count" bacteriuria in young women with acute urinary symptoms. Ann Intern Med 1993; 119: 454-460.
42. 42. Young HK, Hillyear JK. Trimethoprim resistance in urinary pathogens in northern Scotland: Epidemic spread of a resistance plasmid encoding the type Ib trimethoprim-resistant dihydrofolate reductase. J Med Microbiol 1994; 41: 343-348.
43. 43. Martin L. Gonzalez (editor). Socioeconomic Characteristics of Medical Practice 1995. American Medical Association Center for Health Policy Research; American Medical Association, Chicago, Illinois. 1995.